WFA Asset Management’s Gilead Sciences GILD Stock Holding History

WFA Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$17.7K	Buy	211 +2	+1%	+$227	0.01%	140
2025 Q2	$14.3K	Buy	209 +2	+1%	+$213	0.01%	153
2025 Q1	$15.1K	Sell	207 -6	-3%	-$619	0.01%	170
2024 Q4	$19.7K	Buy	213 +2	+0.9%	+$180	0.01%	157
2024 Q3	$17.7K	Buy	211 +2	+1%	+$153	0.01%	141
2024 Q2	$14.3K	Buy	209 +2	+1%	+$133	0.01%	154
2024 Q1	$15.1K	Buy	207 +2	+1%	+$154	0.01%	171
2023 Q4	$16.6K	Buy	205 +2	+1%	+$156	0.01%	151
2023 Q3	$15.2K	Buy	203 +2	+1%	+$154	0.01%	156
2023 Q2	$15.5K	Buy	201 +2	+1%	+$160	0.01%	159
2023 Q1	$16.5K	Buy	199 +2	+1%	+$166	0.01%	151
2022 Q4	$16.9K	Buy	197 +2	+1%	+$158	0.01%	136
2022 Q3	$12.1K	Buy	195 +2	+1%	+$126	0.01%	148
2022 Q2	$11.9K	Buy	193 +2	+1%	+$124	0.01%	146
2022 Q1	$11.3K	Buy	191 +2	+1%	+$128	0.01%	151
2021 Q4	$13.7K	Buy	+189	New	+$13K	0.01%	139

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WFA Asset Management's GILD Position: Q3 2025 in Review

WFA Asset Management increased its Gilead Sciences (GILD) stake by 0.96% in Q3 2025, buying an estimated $227 and bringing the position to 211 shares worth $17.7K. The position accounts for 0.01% of the portfolio, ranked #140.

WFA Asset Management first reported a position in GILD in Q4 2021 and has held it in 16 quarters since. The position peaked at $19.7K in Q4 2024. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

WFA Asset Management held 211 shares of Gilead Sciences worth $17.7K as of Q3 2025.
WFA Asset Management bought 2 Gilead Sciences shares in Q3 2025, an estimated $227.
Gilead Sciences made up 0.01% of WFA Asset Management's portfolio in Q3 2025, its #140 holding.
WFA Asset Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 16 quarters since.
WFA Asset Management's Gilead Sciences position peaked at $19.7K in Q4 2024.
2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on WFA Asset Management's 13F filing for Q3 2025, filed 30 Oct 2025.